- Home
- AVB vs DXCM Comparison
AVB vs DXCM Comparison
Compare AVB & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVB | DXCM |
|---|---|---|
| Founded | 1978 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5B | 25.9B |
| IPO Year | 1994 | 2005 |
Fundamental Metrics
Financial Performance| Metric | AVB | DXCM |
|---|---|---|
| Price | $183.78 | $69.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 21 |
| Target Price | ★ $205.70 | $86.86 |
| AVG Volume (30 Days) | 1.1M | ★ 4.5M |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | ★ 3.88% | N/A |
| EPS Growth | ★ 12.03 | 7.75 |
| EPS | ★ 8.20 | 1.80 |
| Revenue | $3,065,608,000.00 | ★ $4,515,900,000.00 |
| Revenue This Year | $3.39 | $17.38 |
| Revenue Next Year | $4.14 | $12.76 |
| P/E Ratio | ★ $21.98 | $37.65 |
| Revenue Growth | 6.50 | ★ 14.21 |
| 52 Week Low | $166.73 | $54.11 |
| 52 Week High | $230.21 | $93.25 |
Technical Indicators
Market Signals| Indicator | AVB | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 58.10 | 67.24 |
| Support Level | $178.59 | $65.19 |
| Resistance Level | $185.64 | $68.18 |
| Average True Range (ATR) | 2.82 | 1.51 |
| MACD | 0.22 | 0.09 |
| Stochastic Oscillator | 83.59 | 93.22 |
Price Performance
Historical ComparisonAbout AVB AvalonBay Communities Inc.
AvalonBay Communities owns a portfolio of 295 apartment communities with almost 90,000 units and is developing 20 additional properties with approximately 7,300 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.